The primary use of<unk>  is for the treatment of leprosy. Other uses have not been proven to be safe or effective. It has been studied in combination with other antimycobacterial drugs to treat Mycobacterium avium infections in people with HIV/AIDS and Mycobacterium avium paratuberculosis.<unk>  also has a marked anti-inflammatory effect and is given to control the leprosy reaction, erythema nodosum leprosum (ENL). (From AMA Drug Evaluations Annual, 1993, p1619). The drug is given as an alternative to people who can not tolerate the effects of dapsone for leprosy. Early research suggested<unk>  inhibits the replication of SARS-CoV-2 in vitro and reduce viral load and inflammation in the lung in animal models
Clofazimine
Fursultiamine
Miproxifene phosphate
Nalmefene
Ipriflavone
Dimetacrine
Isoniazid
Miproxifene